These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38627642)

  • 1. Implementation of a rapid diagnostic assay package for cryptococcosis, histoplasmosis and tuberculosis in people living with HIV in Paraguay.
    Aguilar G; Lopez G; Sued O; Medina N; Caceres DH; Pereira J; Jordan A; Lezcano V; Vicenti C; Benitez G; Samudio T; Perez F
    BMC Infect Dis; 2024 Apr; 24(1):406. PubMed ID: 38627642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of rapid diagnostics assays for detection of histoplasmosis and cryptococcosis in central american people living with HIV.
    Caceres DH; Arauz AB; Flores C; Santiago E; Montoya S; Saenz C; Torres-Meneses FA; Peralta H; Zuniga-Moya JC; Lainez Arteaga IZ; Garcia A; Abdo J; Verweij PE; Chiller TM; Forno D
    Mycoses; 2021 Nov; 64(11):1396-1401. PubMed ID: 33966300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of fungal opportunistic infections in people living with HIV from Guatemala and El Salvador.
    Forno D; Samayoa B; Medina N; Arathoon E; Mejia CR; Gordillo R; Cedillos R; Rodas J; Ahlquist Cleveland A; Chiller T; Caceres DH
    Mycoses; 2021 Dec; 64(12):1563-1570. PubMed ID: 34536307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda.
    Manabe YC; Nonyane BA; Nakiyingi L; Mbabazi O; Lubega G; Shah M; Moulton LH; Joloba M; Ellner J; Dorman SE
    PLoS One; 2014; 9(7):e101459. PubMed ID: 25000489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of tuberculosis and cryptococcal meningitis rapid diagnostic tests amongst patients with advanced HIV at Kamuzu Central Hospital, Malawi, 2016-2017.
    Kanyama C; Chagomerana MB; Chawinga C; Ngoma J; Shumba I; Kumwenda W; Armando B; Kumwenda T; Kumwenda E; Hosseinipour MC
    BMC Infect Dis; 2022 Mar; 22(1):224. PubMed ID: 35247971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic Cryptococcal Antigenemia in People Living with HIV (PLHIV) with Severe Immunosuppression: Is Routine CrAg Screening Indicated in India?
    Anuradha S; H AN; Dewan R; Kaur R; Rajeshwari K
    J Assoc Physicians India; 2017 Apr; 65(4):14-17. PubMed ID: 28527158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative performance of the laboratory assays used by a Diagnostic Laboratory Hub for opportunistic infections in people living with HIV.
    Medina N; Alastruey-Izquierdo A; Mercado D; Bonilla O; Pérez JC; Aguirre L; Samayoa B; Arathoon E; Denning DW; Rodriguez-Tudela JL;
    AIDS; 2020 Sep; 34(11):1625-1632. PubMed ID: 32694415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved detection and management of advanced HIV disease through a community adult TB-contact tracing intervention with same-day provision of the WHO-recommended package of care including ART initiation in a rural district of Mozambique.
    Izco S; Murias-Closas A; Jordan AM; Greene G; Catorze N; Chiconela H; Garcia JI; Blanco-Arevalo A; Febrer A; Casellas A; Saavedra B; Chiller T; Nhampossa T; Garcia-Basteiro A; Letang E
    J Int AIDS Soc; 2021 Aug; 24(8):e25775. PubMed ID: 34347366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for invasive fungal disease using non-culture-based assays among inpatients with advanced HIV disease at a large academic hospital in South Africa.
    van Schalkwyk E; Mhlanga M; Maphanga TG; Mpembe RS; Shillubane A; Iyaloo S; Tsotetsi E; Pieton K; Karstaedt AS; Sahid F; Menezes CN; Tsitsi M; Motau A; Wadula J; Seetharam S; van den Berg E; Sriruttan C; Govender NP
    Mycoses; 2020 May; 63(5):478-487. PubMed ID: 32125004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Rapid Screening Program for Histoplasmosis, Tuberculosis, and Cryptococcosis Reduces Mortality in HIV Patients from Guatemala.
    Medina N; Alastruey-Izquierdo A; Bonilla O; Gamboa O; Mercado D; Pérez JC; Salazar LR; Arathoon E; Denning DW; Rodriguez-Tudela JL
    J Fungi (Basel); 2021 Apr; 7(4):. PubMed ID: 33916153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory Reflex and Clinic-Based Point-of-Care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality Among People Living With HIV.
    Drain PK; Galagan SR; Govere S; Krows M; Thulare H; Wallis CL; Gosnell BI; Moosa MY; Celum C; Bassett IV
    J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1205-1213. PubMed ID: 33990495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the lateral flow urine lipoarabinomannan tuberculosis assay in patients with advanced HIV disease at antiretroviral therapy centres in Mumbai, India.
    Acharya S; Deshpande P; Asirvatham ES; Palkar A; Sarman CJ; Laxmeshwar C; Setia MS; Rathod D; Koli S; Dale J; Yeldandi V; Allam R; Agarwal R; Verma S; Upadhyaya S; Nyendak M
    PLoS One; 2022; 17(9):e0273970. PubMed ID: 36103506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis and budgetary impact of the Cryptococcal Antigen Lateral Flow Assay (CRAG-LFA) implementation for the screening and diagnosis of cryptococcosis in asymptomatic people living with HIV in Brazil.
    Vianna CMM; Mosegui GBG
    Rev Inst Med Trop Sao Paulo; 2021; 63():e57. PubMed ID: 34231822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing advanced HIV disease and mortality in global HIV programming.
    Boyd AT; Oboho I; Paulin H; Ali H; Godfrey C; Date A; Sean Cavanaugh J
    AIDS Res Ther; 2020 Jul; 17(1):40. PubMed ID: 32650797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics, diagnosis, treatment and outcomes of patients living with HIV and co-infected with tuberculosis and histoplasmosis: a 5-y retrospective case series.
    Castellanos Reynosa ME; Caal ME; Mercado D; Medina N; Pérez JC; Emeto TI; Arathoon E
    Trans R Soc Trop Med Hyg; 2024 Jun; 118(6):391-398. PubMed ID: 38279781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda.
    Andama AO; den Boon S; Meya D; Cattamanchi A; Worodria W; Davis JL; Walter ND; Yoo SD; Kalema N; Haller B; Huang L;
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):189-94. PubMed ID: 23542636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced HIV disease management practices within inpatient medicine units at a referral hospital in Zambia: a retrospective chart review.
    Mbewe N; Vinikoor MJ; Fwoloshi S; Mwitumwa M; Lakhi S; Sivile S; Yavatkar M; Lindsay B; Stafford K; Hachaambwa L; Mulenga L; Claassen CW
    AIDS Res Ther; 2022 Feb; 19(1):10. PubMed ID: 35193598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease.
    Coetzee LM; Cassim N; Sriruttan C; Mhlanga M; Govender NP; Glencross DK
    PLoS One; 2018; 13(6):e0198993. PubMed ID: 29894509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of histoplasmosis and cryptococcal antigenemia among patients attending a large HIV clinic in Trinidad.
    Edwards RJ; Todd S; Edwards J; Samaroo-Francis W; Lyons N; Boyce G; Denning DW
    Diagn Microbiol Infect Dis; 2023 Aug; 106(4):115952. PubMed ID: 37267742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid CD4 cell count determination and
    Andreani M; Frola CE; Cáceres DH; Bozzano C; Diaz L; Cattani ME; Rodriguez-Tudela JL; Rolón MJ; Guelfand L
    IJID Reg; 2024 Sep; 12():100403. PubMed ID: 39188885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.